NASDAQ
26.03.25
20:43 Uhr
21,920 US-Dollar
0,000
0,00 %
0,00 %
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | |
|---|---|---|---|---|
| Mi | Cathie Wood's ARK focuses on Beam Therapeutics, Intuitive Machines stock | 9 | Investing.com | |
| Di | Beam Therapeutics stock holds firm with $37 target at Bernstein | 1 | Investing.com | |
| 13.03. | Citi lifts Beam Therapeutics stock price target to $64 | 6 | Investing.com | |
| 11.03. | Beam Therapeutics (NASDAQ:BEAM) Stock Rating Upgraded by Jones Trading | 2 | MarketBeat | |
| 11.03. | Beam Therapeutics (NASDAQ:BEAM) Rating Increased to Sector Outperform at Scotiabank | 3 | MarketBeat | |
| 11.03. | Beam Therapeutics stock target holds at $37 on positive trial data | 5 | Investing.com | |
| BEAM THERAPEUTICS Aktie jetzt für 0€ handeln | ||||
| 10.03. | Beam Therapeutics Inc. - 8-K, Current Report | 2 | SEC Filings | |
| 10.03. | Gene Edit Biotech Beam Therapeutics Touts Encouraging Data From Early-Stage Gene Therapy Study In Genetic Disorder, Raises $500 Million Via Equity | 5 | Benzinga.com | |
| 10.03. | Beam Therapeutics stock soars on positive BEAM-302 trial data | 6 | Investing.com | |
| 10.03. | Beam Therapeutics Reprots Positive Initial Phase 1/2 Data For BEAM-302 In AATD | 266 | AFX News | |
| 10.03. | Beam Therapeutics prices $500M offering | 13 | Seeking Alpha | |
| 10.03. | Beam Therapeutics Announces Pricing of Underwritten Offering | 11 | GlobeNewswire (USA) | |
| 03.03. | H.C. Wainwright maintains $80 target on Beam Therapeutics stock | 1 | Investing.com | |
| 03.03. | Scotiabank raises Beam Therapeutics stock target to $25 | 8 | Investing.com | |
| 01.03. | Beam Therapeutics (NASDAQ:BEAM) Receives "Buy" Rating from HC Wainwright | 1 | MarketBeat | |
| 27.02. | Analyst Expectations For Beam Therapeutics' Future | 3 | Benzinga.com | |
| 26.02. | Beam Therapeutics' Q4 Earnings & Revenues Beat Estimates | 3 | Zacks | |
| 25.02. | Beam Therapeutics GAAP EPS of -$1.09 beats by $0.09 | 8 | Seeking Alpha | |
| 25.02. | Beam Therapeutics Inc. Q4 Earnings Summary | 303 | AFX News | |
| 25.02. | Beam Therapeutics Inc. - S-8, Securities to be offered to employees in employee benefit plans | 3 | SEC Filings |
Seite:
1 2 3 4 Weiter >>
72 Nachrichten in den letzten 12 Monaten
BEAM THERAPEUTICS INC gehört der Branche Biotechnologie an. Mit einer aktuellen Kursveränderung von 0,000 (0,00 %) liegt der Kurs bei 21,920 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu BEAM THERAPEUTICS INC finden Sie auf Wallstreet Online.
